Pharma & Biotech VC & Investment News
Biotechnology
Danish life sciences investor Novo Holdings is continuing the spread of its cash pile, this time as co-leader of a $181.4 million Series D financing in Alentis Therapeutics. 12 November 2024
Today's issue
Refine Search
Biotechnology
California-based venture capital firm Versant Ventures yesterday announced the launch of Pep2Tango Therapeutics, a start-up focused on innovative, next-generation weight loss therapies. Proceeds from the significant, undisclosed round will support development of the company’s novel unimolecular tetra-receptor agonist peptides to treat obesity and related conditions. 22 November 2024
Biotechnology
Hong Kong-based Sino Biopharm has signed an equity investment and strategic collaboration agreement with LaNova Medicines, advancing its oncology focus. 22 November 2024
Biotechnology
Colorado, USA-based biotech Enveda Biosciences, which is using AI to translate nature into new medicines, has announced an oversubscribed $130 million Series C funding round led by Kinnevik and FPV. 22 November 2024
Biotechnology
San Diego-based Cidara Therapeutics, a biotech using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, has entered into a securities purchase agreement with certain investors to raise up to around $105 million. 21 November 2024
Biotechnology
Aizen Therapeutics, an AI-driven biotech headquartered in San Diego, has officially launched from stealth mode, introducing its drug discovery platform, DaX. 21 November 2024
Biotechnology
San Diego-based Valora Therapeutics, a biotech that boasts of having a novel approach to immunotherapy, has announced the successful closing of a $30 million seed funding round. 21 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
Shanghai-based Leading Tac Pharmaceutical has announced the successful completion of a series A financing round, raising over 100 million yuan ($14 million). 21 November 2024
Biotechnology
A pair of industry veterans have teamed up to create Jupiter Bioventures, a San Francisco-based biotech venture foundry promised to build bold, science-driven therapeutics companies. 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Californian oncology-focused biotech Avenzo Therapeutics has announced a pair of important updates. 19 November 2024
Pharmaceutical
In yet another sign of the mounting interest in radiopharmaceuticals, Tongrui Biopharma, a Chinese innovator in this area, has announced the completion of a $100 million series A+ financing round. 18 November 2024
Biotechnology
Shanghai-based biopharma Zai Lab has announced the pricing of its underwritten public offering at $25.50 per share, aiming to raise around $200 million. 15 November 2024
Pharmaceutical
New York-based Metsera, a biopharma developing medicines for obesity and metabolic diseases, has closed a $215 million Series B financing to further advance its portfolio of clinical-stage, nutrient-stimulated hormone (NuSH) analog peptides. 14 November 2024
Pharmaceutical
Life science investor Syncona has announced the launch of its newest portfolio company, Slingshot Therapeutics, through the Syncona Accelerator initiative. 14 November 2024
Biotechnology
Danish life sciences investor Novo Holdings is continuing the spread of its cash pile, this time as co-leader of a $181.4 million Series D financing in Alentis Therapeutics. 12 November 2024
Biotechnology
Trace Neuroscience, a newly launched biopharma based in San Francisco, aims to advance treatments for neurodegenerative diseases, starting with amyotrophic lateral sclerosis (ALS). 12 November 2024
Biotechnology
Geron Corporation, a biopharma company focused on telomerase inhibition therapies, has announced a $375 million financing agreement aimed at supporting the commercial rollout of Rytelo (imetelstat). 11 November 2024
Biotechnology
An Expert View from Cumulus Oncology about its innovative business model, which is all about improving the efficiency of drug R&D. 11 November 2024
Biotechnology
US biotech venture fund Aditum Bio and China’s Leads Biolabs today announced the formation of Oblenio Bio, marking the thirteenth company launched by Aditum. 7 November 2024
Pharmaceutical
Bristol-Myers Squibb has posted profits from the latest quarter that missed analysts’ expectations. 26 October 2017
Pharmaceutical
Germany’s Bayer saw its shares fall as much as 3.5% to 110.85 euros this morning, after the company released its third-quarter 2017 financial results, which showed that sales were dragged down by its consumer health business. 26 October 2017
Biotechnology
Third quarter financial results from Amgen show a slight fall in revenue, coming in around analysts’ expectations at $5.8 billion. 26 October 2017
Pharmaceutical
Despite reporting significant sales growth for the third-quarter of 2017, French biopharma firm Ipsen saw its shares drop 6.43% to 105.50 euros in morning trading. 26 October 2017
Pharmaceutical
There did not appear too much to worry investors in the third-quarter financial results of the UK’s biggest pharma company, GlaxoSmithKline, as they were presented on Tuesday. 26 October 2017
Pharmaceutical
Swedish Orphan Biovitrum saw its share rise 4.33% to 122.90 Swedish kronor, after it announced its results for the third quarter 2017, with earnings beating analysts’ expectations. 25 October 2017
Pharmaceutical
Eli Lilly reported revenue and earnings figures for the third quarter of 2017 that narrowly exceeded the expectations of Wall Street analysts on Tuesday. 24 October 2017
Biotechnology
The USA’s Biogen has released its third quarter financial results statement, revealing better-than-expected profit and revenue figures. 24 October 2017
Pharmaceutical
Swiss pharma giant Novartis this morning reported that sales for the first quarter of 2017 rose 2% to $12.4 billion, beating the Reuters poll average of $12.2 billion. 24 October 2017
Pharmaceutical
UCB has posted financials, reporting that revenue for the first nine months of 2017 came in at 3.3 billion euros ($$3.89 billion), an increase of 9% at actual and at constant exchange rates (CER). 23 October 2017
Pharmaceutical
On the regulatory front, the big news last week was Gilead Sciences’ newly-acquired Kite Pharma gaining US Food and Drug Administration approval for its Yescarta, the second CAR-T therapy to be cleared for marketing in the USA. Also, there was Aerie getting a favorable FDA advisory panel vote on its Rhopressa. Attracting attentions elsewhere, Celgene had a big disappointment with its Crohn’s disease candidate mongersen, French firm Exelixis’ liver cancer drug cabozantinib; invalidation of Allergan’s ophthalmic product Restasis patents; and better-than expected financials from Johnson & Johnson. 22 October 2017
Pharmaceutical
Swiss pharma giant Roche says its third-quarter 2017 sales were 13.1 billion Swiss francs ($13.37 billion), compared to the 13.04 billion francs average estimate by analysts in a Reuters poll. 19 October 2017
Pharmaceutical
In this week's feature, Michael Jewell, the healthcare partner at Cavendish Corporate Finance, looks at a new initiative by Pfizer, the world’s largest pharmaceutical company, that aims to shake up the way the industry approaches nascent experimental drugs which would otherwise be side-lined. 17 October 2017
Pharmaceutical
Johnson & Johnson, the world’s largest healthcare company, looked set to open trading on Tuesday around 1% up on the previous close, after its third-quarter financial results exceeded the expectations of analysts. 17 October 2017
Pharmaceutical
A report on pharma’s contract development and manufacturing organization sector says that this space is currently beset by uncertainty. 13 October 2017
Biotechnology
UK biotech firm Redx Pharma is one step closer to being able to exit administration and recommence trading on the London Stock Exchange. 13 October 2017
Biotechnology
Against a tumultuous political backdrop in which several large businesses look set to decamp, Catalonia’s biopharmaceutical sector is reportedly thriving. 12 October 2017
Generics
There have been some challenging days in the recent history of Teva Pharmaceutical Industries, and Wednesday would certainly come into that category. 5 October 2017
Pharmaceutical
There was an emphasis on good times ahead in the communications put out by Merck KGaA as the German life sciences and pharma company welcomed analysts and investors to its 2017 Capital Markets Day on Thursday. 28 September 2017
Biotechnology
Brandishing a 75 million-euro loan courtesy of the European Commission’s Investment Plan for Europe, German biotech firm Evotec has gone shopping. 28 September 2017
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze